RMD

RESMED INC

NYSE, OTC · CIK 943819

Last close218.89
Daily change-2.26 (-1.02%)
10 Years gain+267.51%
Dividends TTM2.46 (+12.33%)
Dividend yield1.11%

Fundamental Analysis

RMD · STANDARD

SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 0630

Screener
Fundamental
84.9
Momentum
70.6
Acceleration
75.4
Confidence
100.0
Annual Revenue18
Quarterly Revenue51
Annual CFO16
Balance SheetAvailable
RankingEligible

Score Breakdown

Growth17.7 / 25
Quality21.5 / 25
Capital Efficiency18.2 / 20
Balance Sheet14.6 / 15
Shareholder Economics8.9 / 10
Forward Indicators4.0 / 5

Signals

Gross margin expansionGross margin improved by 3.5344 percentage points.
Operating leverageOperating margin improved by 4.1268 percentage points.
FCF growthFree cash flow grew 47.1379%.
ROIC expansionROIC improved by 6.5282 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 1.192%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.

Key Metrics

Revenue Growth TTM12.64%OK
Revenue CAGR 3Y10.21%OK
Gross Margin61.24%OK
Operating Margin34.01%OK
FCF Margin32.91%OK
FCF Growth47.14%OK
ROIC27.01%OK
Incremental Operating Margin 3Y43.72%OK
Net Debt / CFO-0.65xOK
Diluted Share Growth 1Y-1.19%OK
SBC / Revenue1.84%OK
SBC / FCF5.6%OK

Financial History

PeriodRevenueGross ProfitOperating IncomeCFOFCFGross MarginOp MarginFCF MarginROICShares
2026 FY Jun 30, 2026$5.65B$3.45B$1.89B$1.81B$1.65B61.06%33.37%29.18%27.39%146.05M
2026 FY Jun 30, 2025$5.15B$3.05B$1.69B$1.75B$1.66B59.36%32.75%32.29%26.21%147.34M
2026 FY Jun 30, 2024$4.69B$2.66B$1.32B$1.40B$1.30B56.67%28.17%27.78%20%147.55M
2025 FY Jun 30, 2023$4.22B$2.36B$1.13B$693.30M$573.63M55.78%26.8%13.58%20.08%147.46M
2024 FY Jun 30, 2022$3.58B$2.02B$1.00B$351.15M$216.31M56.57%27.96%6.05%22.91%147.04M

Formula Trace

MetricValueFormulaStatusSource
Revenue TTM$5.48Bsum latest 4 fiscal quarters RevenueOK0000943819-26-000025, 0000943819-25-000090
Revenue Growth TTM12.64%Revenue_TTM / Revenue_TTM_1Y_ago - 1OK0000943819-26-000025, 0000943819-25-000090
Revenue CAGR 3Y10.21%(Revenue_current / Revenue_3Y_ago)^(1/3) - 1OK0000943819-26-000047
Revenue CAGR 5Y12.08%(Revenue_current / Revenue_5Y_ago)^(1/5) - 1OK0000943819-26-000047
Gross Profit CAGR 3Y13.58%(GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1OK0000943819-26-000047
Operating Income Growth28.2%OperatingIncome_current / OperatingIncome_prior_year - 1OK0000943819-26-000025, 0000943819-25-000090
FCF Growth47.14%FCF_current / FCF_prior_year - 1OK0000943819-26-000025, 0000943819-26-000007
Revenue Growth Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Gross Profit Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Operating Income Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
FCF Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Gross Margin61.24%Gross Profit / RevenueOK0000943819-26-000025, 0000943819-25-000090
Operating Margin34.01%Operating Income / RevenueOK0000943819-26-000025, 0000943819-25-000090
FCF Margin32.91%(CFO - CapEx) / RevenueOK0000943819-26-000025, 0000943819-26-000007
ROIC27.01%NOPAT / Average Invested CapitalOK0000943819-26-000025, 0000943819-25-000090
Net Debt / CFO-0.65xNet Debt / CFOOK0000943819-26-000025, 0000943819-26-000007
Current Ratio3.01xCurrent Assets / Current LiabilitiesOKderived
Cash / Debt4.11x(Cash + Short-term Investments) / Total DebtOK0000943819-26-000025